Naltrexone for Heavy Drinking in Young Adults: A Double-Blind Placebo Controlled Trial

Project: Research project

Project Details


Although Dr. Corbin is relocating to Arizona State University, he will continue to serve as a co-investigator on the project dedicating 10% effort during the academic years 2, 3, 4 and 25% during the summer (33% in year four of the subcontract). Dr. Corbin will continue to participate in regular meetings related to the project by phone and he will make one trip each year to Yale to work directly with the PI and other project staff. In addition, Dr. Corbin will be one of two research staff responsible for reviewing and rating audiotapes of the BASICS counseling sessions. He will also help manage the data as it is collected and provide regular reports to the research team. These reports will help guide decisions about continued recruitment efforts and methods for maximizing the validity and comprehensiveness of the data. Finally, Dr. Corbin will assist with the preparation of Data Safety and Monitoring Plan reports and progress reports to the funding source. In later years when the data collection is complete, Dr. Corbin will be integrally involved in data analyses and manuscript preparation. Dr. Corbin will be transitioning to a similar position at ASU (Associate Professor with tenure) with a very similar distribution of responsibilities with respect to research, teaching, and service. Thus, he will continue to have adequate time to devote to the project. Dr. Corbin will also have very similar resources with respect to computing, statistical software, etc. Human subjects approval has already been obtained for the responsibilities Dr. Corbin will be performing following his transfer to ASU.
Effective start/end date7/1/098/31/12


  • US Department of Health & Human Services (HHS): $145,579.00


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.